These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28290081)

  • 21. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.
    Tansey KE; Rucker JJ; Kavanagh DH; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans DM; Hauser J; Henigsberg N; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Lewis G; Kapur S; McGuffin P; Uher R
    Pharmacogenomics J; 2014 Aug; 14(4):395-9. PubMed ID: 24445990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide: Antidepressant mechanisms and inflammation.
    Ghasemi M
    Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.
    Saragoussi D; Chollet J; Bineau S; Chalem Y; Milea D
    Int J Clin Pract; 2012 Nov; 66(11):1079-87. PubMed ID: 23067031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal temporal difference reward-learning signals in major depression.
    Kumar P; Waiter G; Ahearn T; Milders M; Reid I; Steele JD
    Brain; 2008 Aug; 131(Pt 8):2084-93. PubMed ID: 18579575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-based immune-endocrine biomarkers of treatment response in depression.
    Chan MK; Cooper JD; Bot M; Birkenhager TK; Bergink V; Drexhage HA; Steiner J; Rothermundt M; Penninx BW; Bahn S
    J Psychiatr Res; 2016 Dec; 83():249-259. PubMed ID: 27693950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene × environment interactions in the prediction of response to antidepressant treatment.
    Klengel T; Binder EB
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Epigenetic Tools to Investigate Antidepressant Response.
    Fiori LM; Lin R; Ju C; Belzeaux R; Turecki G
    Prog Mol Biol Transl Sci; 2018; 158():255-272. PubMed ID: 30072056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the use of antidepressants in children and adolescents.
    Tandon M; Pruett JR
    Mo Med; 2008; 105(1):79-84; quiz 84-5. PubMed ID: 18300611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptomic and epigenomic biomarkers of antidepressant response.
    Belzeaux R; Lin R; Ju C; Chay MA; Fiori LM; Lutz PE; Turecki G
    J Affect Disord; 2018 Jun; 233():36-44. PubMed ID: 28918100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical discovery of duloxetine for the treatment of depression.
    Torres-Sanchez S; Perez-Caballero L; Mico JA; Elorza J; Berrocoso E
    Expert Opin Drug Discov; 2012 Aug; 7(8):745-55. PubMed ID: 22680253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
    Berk M; Dodd S
    Med Hypotheses; 2005; 65(1):39-43. PubMed ID: 15893115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities.
    Rahman S; Alzarea S
    Prog Mol Biol Transl Sci; 2019; 167():159-178. PubMed ID: 31601403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness.
    Bauer M; Rush AJ; Ricken R; Pilhatsch M; Adli M
    Pharmacopsychiatry; 2019 Mar; 52(3):117-125. PubMed ID: 29986372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prediction and Personalized Medicine of Antidepressant Treatment in Japanese MDD Patient].
    Kato M
    Seishin Shinkeigaku Zasshi; 2016; 118(3):139-146. PubMed ID: 30620509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.